SABRA HEALTH CARE REIT, INC.: 10-K filed 2013-03-14
What SABRA HEALTH CARE REIT, INC. reported in its annual report filed 2013-03-14 (fiscal FY 2012): 25 published measures, 72 facts as tagged in accession 0001492298-13-000009.
This filing
- Form
- 10-K (annual report)
- Filed
- 2013-03-14
- Fiscal period
- fiscal FY 2012
- Accession
- 0001492298-13-000009 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SABRA HEALTH CARE REIT, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | 916,882,000 | USD | |
| At 2011-12-31 | 749,650,000 | USD | |
| At 2010-11-14 | 595,923,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | 611,394,000 | USD | |
| At 2011-12-31 | 423,077,000 | USD | |
| At 2010-11-14 | 418,732,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | 305,488,000 | USD | |
| At 2011-12-31 | 326,573,000 | USD | |
| At 2010-11-15 | 177,191,000 | USD | |
| At 2010-11-14 | 177,191,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | 17,101,000 | USD | |
| At 2011-12-31 | 42,250,000 | USD | |
| At 2010-12-31 | 74,233,000 | USD | |
| At 2010-11-15 | 0 | USD | |
| At 2010-11-14 | 67,134,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 19,513,000 | USD | 366 |
| 2011-01-01 to 2011-12-31 | 12,842,000 | USD | 365 |
| 2010-11-16 to 2010-12-31 | 7,000 | USD | 46 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 56,252,000 | USD | 366 |
| 2011-01-01 to 2011-12-31 | 44,705,000 | USD | 365 |
| 2010-11-16 to 2010-12-31 | 6,592,000 | USD | 46 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 103,170,000 | USD | 366 |
| 2011-01-01 to 2011-12-31 | 84,225,000 | USD | 365 |
| 2010-11-16 to 2010-12-31 | 8,795,000 | USD | 46 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 137,249,000 | USD | 366 |
| 2011-01-01 to 2011-12-31 | 127,898,000 | USD | 365 |
| 2010-11-16 to 2010-12-31 | 523,000 | USD | 46 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | -218,650,000 | USD | 366 |
| 2011-01-01 to 2011-12-31 | -204,586,000 | USD | 365 |
| 2010-11-16 to 2010-12-31 | 67,118,000 | USD | 46 |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 37,061,111 | shares | 366 |
| 2011-01-01 to 2011-12-31 | 30,109,417 | shares | 365 |
| 2010-11-16 to 2010-12-31 | 25,110,936 | shares | 46 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 37,321,517 | shares | 366 |
| 2011-01-01 to 2011-12-31 | 30,171,225 | shares | 365 |
| 2010-11-16 to 2010-12-31 | 25,186,988 | shares | 46 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 0.53 | USD/shares | 366 |
| 2011-01-01 to 2011-12-31 | 0.43 | USD/shares | 365 |
| 2010-11-16 to 2010-12-31 | 0 | USD/shares | 46 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 0.52 | USD/shares | 366 |
| 2011-01-01 to 2011-12-31 | 0.43 | USD/shares | 365 |
| 2010-11-16 to 2010-12-31 | 0 | USD/shares | 46 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 0 | USD | 366 |
| 2011-01-01 to 2011-12-31 | 0 | USD | 365 |
| 2010-11-16 to 2010-12-31 | 242,000 | USD | 46 |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 8,279,000 | USD | 366 |
| 2011-01-01 to 2011-12-31 | 4,600,000 | USD | 365 |
| 2010-11-16 to 2010-12-31 | 335,000 | USD | 46 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | 37,099,202 | shares | |
| At 2011-12-31 | 36,891,712 | shares | |
| At 2010-11-14 | 25,061,072 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | 353,861,000 | USD | |
| At 2011-12-31 | 344,995,000 | USD | |
| At 2010-11-14 | 176,940,000 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | 569,822,000 | USD |
Net deferred tax assets
Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | 24,212,000 | USD | |
| At 2011-12-31 | 25,540,000 | USD | |
| At 2010-11-14 | 26,542,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-11-16 to 2010-12-31 | 249,000 | USD | 46 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 16,104,000 | USD | 366 |
| 2011-01-01 to 2011-12-31 | 14,473,000 | USD | 365 |
| 2010-11-16 to 2010-12-31 | 1,553,000 | USD | 46 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 30,263,000 | USD | 366 |
| 2011-01-01 to 2011-12-31 | 26,591,000 | USD | 365 |
| 2010-11-16 to 2010-12-31 | 3,134,000 | USD | 46 |
Current income tax expense or benefit
Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-11-16 to 2010-12-31 | 0 | USD | 46 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 0 | USD | 366 |
| 2011-01-01 to 2011-12-31 | 0 | USD | 365 |
| 2010-11-16 to 2010-12-31 | 242,000 | USD | 46 |
Proceeds from issuing common stock
Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 53,000 | USD | 366 |
| 2011-01-01 to 2011-12-31 | 163,242,000 | USD | 365 |
| 2010-11-16 to 2010-12-31 | 0 | USD | 46 |
Inspect the source
- Entity
- SABRA HEALTH CARE REIT, INC. / CIK 0001492298
- Captured
- 2026-09-20T09:10:10.598Z
- SEC response SHA-256
e70eb840bd5aa8e83d03d1eb05aaccf39d18ee8d15b4193bfd620bd0c0f918d7
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001492298.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))